Actively Recruiting
Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers
Led by Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. · Updated on 2025-04-25
150
Participants Needed
17
Research Sites
199 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a Phase I study to evaluate the safety, tolerability, and efficacy of TQB2922 for injection in subjects with advanced cancers
CONDITIONS
Official Title
Clinical Trial of TQB2922 for Injection in Patients With Advanced Cancers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Subjects voluntarily join this study, sign the informed consent form, and have good compliance
- Age between 18 and 75 years
- Eastern Cooperative Oncology Group (ECOG) performance status score of 0 or 1
- Expected survival of more than 3 months
- Histological or cytological diagnosis of advanced cancers
- Advanced malignancies with failed standard therapy or lack of effective treatment
- Major organs functioning well
- Female and male subjects of childbearing potential agree to use contraception during the study and for 6 months after completion
You will not qualify if you...
- Current or previous other malignancies within 2 years before the first dose
- Unresolved toxicity of Grade 1 or above from prior anti-tumor therapy
- Significant surgery, biopsy, or traumatic injury within 28 days before the first dose
- Long-term unhealed wounds or fractures
- Cerebrovascular accident, deep vein thrombosis, or pulmonary embolism within 6 months before the first dose
- History of psychotropic drug abuse without abstinence or mental disorders
- Any severe and/or uncontrolled disease
- Live attenuated vaccination within 2 weeks before the first dose or planned during the study
- History of unexplained severe allergies or hypersensitivity to monoclonal antibodies, immunoglobulins, TQB2922, or its excipients
- Investigator judgment of serious concomitant diseases or other reasons making the subject unsuitable for enrollment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 17 locations
1
Chongqing University Cancer Hospital
Chongqing, Chongqing Municipality, China, 400030
Not Yet Recruiting
2
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, China, 510060
Actively Recruiting
3
The first affiliated hospital of Guangzhou medical university
Guangzhou, Guangdong, China, 510062
Not Yet Recruiting
4
Harbin Medical University Cancer Hospital
Harbin, Heilongjiang, China, 150081
Not Yet Recruiting
5
Henan Cancer Hospital
Zhengzhou, Henan, China, 450003
Not Yet Recruiting
6
Henan Provincine People's Hospital
Zhengzhou, Henan, China, 450003
Not Yet Recruiting
7
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, China, 450052
Not Yet Recruiting
8
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China, 410011
Not Yet Recruiting
9
Hunan Cancer Hospital
Changsha, Hunan, China, 410013
Not Yet Recruiting
10
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China, 210008
Not Yet Recruiting
11
Affiliated Zhongshan Hospital of Dalian University
Dalian, Liaoming, China, 116001
Not Yet Recruiting
12
Department of Medical Oncology, The First Hospital of China Medical University
Shenyang, Liaoning, China, 110001
Not Yet Recruiting
13
The First Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, China, 7100614
Not Yet Recruiting
14
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, China, 200433
Not Yet Recruiting
15
Affiliated Hospital of North Sichuan Medical College
Nanchong, Sichuan, China, 637000
Not Yet Recruiting
16
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, China, 300060
Not Yet Recruiting
17
Yunnan Cancer Hospital
Kunming, Yunnan, China, 650118
Not Yet Recruiting
Research Team
L
Li Zhang, Doctor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here